ADAPY ADAPTIMMUNE THERAPEUTICS PLC
ADR
CUSIP: 00653A107
FIGI: BBG008G65WC2
Institutional Holders12
Total Institutional Value$90,973
Total Shares Held2,093,722
Avg Position$7,581
Top 5 Holders %99.3%
Alpha-Weighted Score72.8
New Positions+1
Exited Positions-47
Top 15 Institutional Holders by Value
■ New ■ Increased ■ Decreased ■ Unchanged
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|---|---|---|---|---|
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | High Conviction | Minimal Flow | $37,800 (41.6%) | 20,000 | NEW |
| RATHBONES GROUP PLC | High Conviction | Moderate Flow | $22,506 (24.7%) | 865,636 | -60.0% |
| EMPIRICAL FINANCE, LLC | High Conviction | Low Flow | $20,800 (22.9%) | 800,000 | -80.0% |
| XTX TOPCO LTD | Moderate Conviction | Moderate Flow | $9,200 (10.1%) | 353,836 | -31.0% |
| SIMPLEX TRADING, LLC | Moderate Conviction | Market Mover | $483 (0.5%) | 18,610 | 48,200.0% |
| RHUMBLINE ADVISERS | High Conviction | Market Mover | $95 (0.1%) | 3,661 | -87.3% |
| BARCLAYS PLC | High Conviction | Market Mover | $66 (0.1%) | 2,532 | -80.0% |
| Raiffeisen Bank International AG | High Conviction | Moderate Flow | $23 (0.0%) | 907 | -80.5% |
| X-SQUARE CAPITAL, LLC | Moderate Conviction | Minimal Flow | $0 (0.0%) | 11,359 | -100.0% |
| TD WATERHOUSE CANADA INC. | High Conviction | Significant Flow | $0 (0.0%) | 14 | -100.0% |
| ACADIAN ASSET MANAGEMENT LLC | High Conviction | Low Flow | $0 (0.0%) | 17,167 | -100.0% |
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q4 25 | 8 | $0.00B | 2,065,177 | $0.04 |
| Q3 25 | 57 | $0.01B | 43,846,102 | $0.13 |
| Q2 25 | 63 | $0.03B | 115,519,535 | $0.24 |
| Q1 25 | 68 | $0.02B | 116,243,667 | $0.19 |
| Q4 24 | 79 | $0.08B | 140,783,952 | $0.54 |
| Q3 24 | 80 | $0.16B | 169,550,536 | $0.95 |
| Q2 24 | 76 | $0.15B | 155,930,096 | $0.97 |
| Q1 24 | 80 | $0.26B | 163,837,948 | $1.56 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.